Bowel Disease clinical trials

Explore recruiting bowel disease clinical trials.

Recruiting bowel disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bowel Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s Fistulas : ADICROHN II

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Modafinil for debilitating fatigue in quiescent inflammatory bowel disease: a multicentre, randomised, double-blind, placebo-controlled, clinical trial (MODIFI-IBD trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdominal pain.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Multicenter, Double-Blind, Placebo Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy with RO7790121 in Patients with Moderately to Severely Active Crohn's Disease

Italy, France, Belgium, Hungary, Denmark, Romania +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Prospective Multicenter Randomized Controlled, Open-label Study to Compare the Efficacy of Subcutaneous Infliximab Monotherapy with Subcutaneous Infliximab and Concomitant Immunosuppression in the Treatment of Moderate to Severe Crohn’s Disease ( Direct-CD)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A study to learn how the study medicine called [14C]PF-07054894 is processed by the body.

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Bowel Disease trials by city

Bowel Disease in Toronto Bowel Disease in Vancouver Bowel Disease in Montreal Bowel Disease in Calgary Bowel Disease in Edmonton Bowel Disease in Ottawa Bowel Disease in Winnipeg Bowel Disease in Quebec City Bowel Disease in Hamilton Bowel Disease in Kitchener Bowel Disease in London Bowel Disease in Halifax Bowel Disease in New York Bowel Disease in Los Angeles Bowel Disease in Chicago Bowel Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease